Oppenheimer Trims Teladoc Health (NYSE:TDOC) Target Price to $17.00

Teladoc Health (NYSE:TDOC) had its price objective lowered by Oppenheimer from $21.00 to $17.00 in a report released on Thursday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the health services provider’s stock.

TDOC has been the topic of several other reports. Stifel Nicolaus reduced their target price on Teladoc Health from $21.00 to $16.00 and set a hold rating on the stock in a research report on Friday, April 26th. Royal Bank of Canada cut their price objective on Teladoc Health from $25.00 to $18.00 and set an outperform rating on the stock in a report on Friday, April 26th. Bank of America reduced their price objective on Teladoc Health from $16.50 to $13.50 and set a neutral rating on the stock in a research note on Tuesday, May 14th. JPMorgan Chase & Co. reduced their price objective on Teladoc Health from $19.00 to $16.00 and set a neutral rating on the stock in a research note on Tuesday, May 21st. Finally, Needham & Company LLC reaffirmed a hold rating on shares of Teladoc Health in a research note on Friday, April 26th. Thirteen research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of Hold and an average target price of $14.72.

Teladoc Health Price Performance

Shares of TDOC traded down $0.44 during trading hours on Thursday, reaching $8.15. 982,494 shares of the company traded hands, compared to its average volume of 5,403,640. The stock has a fifty day simple moving average of $10.01 and a 200 day simple moving average of $13.82. Teladoc Health has a fifty-two week low of $8.01 and a fifty-two week high of $26.67. The stock has a market capitalization of $1.38 billion, a PE ratio of -5.82 and a beta of 0.94. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67.

Insiders Place Their Bets

In other news, Director Karen L. Daniel sold 9,834 shares of the company’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares in the company, valued at $440,240.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. In the last quarter, insiders sold 15,388 shares of company stock worth $178,225. 0.95% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of TDOC. Vanguard Group Inc. raised its position in shares of Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the period. Dimensional Fund Advisors LP raised its position in Teladoc Health by 25.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after buying an additional 767,999 shares during the period. Norges Bank acquired a new position in Teladoc Health during the fourth quarter valued at $9,714,000. Pale Fire Capital SE acquired a new position in Teladoc Health during the fourth quarter valued at $8,960,000. Finally, Mizuho Markets Americas LLC acquired a new position in Teladoc Health during the second quarter valued at $3,937,000. 76.82% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.